company
Keystone Industries
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-06-24Keystone Industries — Class II recall: Burkhart topical anesthetic gel, benzocaine 20 %, Strawberry Flavor, 1 oz (30 mL…
- fda_recall · drug_recall2026-06-24Keystone Industries — Class II recall: Pearson Quality Topical Anesthetic Gel (20% Benzocaine), Mint Flavor, Net Conten…
- fda_recall · drug_recall2026-06-24Keystone Industries — Class II recall: safco SensiCaine-Ultra (20% Benzocaine), Topical Anesthetic Gel, Strawberry Flav…
- fda_recall · drug_recall2026-06-24Keystone Industries — Class II recall: DHP Topical Anesthetic Gel, Benzocaine 20%, Strawberry Flavor, 1 oz. (30 g), Man…
- fda_recall · drug_recall2026-06-24Keystone Industries — Class II recall: Quala Dental Products, Topical Anesthetic Gel, 20 % Benzocaine, Strawberry Flavo…
- fda_recall · drug_recall2026-06-24Keystone Industries — Class II recall: Dental City TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, Strawberry Flavor, 1 OZ (30…
- fda_recall · drug_recall2026-06-24Keystone Industries — Class II recall: PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL), Strawberry Flavo…
Frequently asked questions
- How many FDA warning letters has Keystone Industries received?
- Argus HQ has not recorded an FDA warning letter for Keystone Industries in our current dataset.
- What FDA recalls has Keystone Industries issued?
- Argus HQ has recorded 7 FDA recalls tied to Keystone Industries.
- Is Keystone Industries FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 7 recalls, and 0 approval records for Keystone Industries. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

